Abstract

Generation of sequence defined antibodies from universal libraries by phage display has been established over the past three decades as a robust method to cope with the increasing market demand in therapy, diagnostics and research. For applications requiring the bivalent antigen binding and an Fc part for detection, phage display generated single chain Fv (scFv) antibody fragments can rapidly be genetically fused to the Fc moiety of an IgG for the production in eukaryotic cells of antibodies with IgG-like properties. In contrast to conversion of scFv into IgG format, the conversion to scFv-Fc requires only a single cloning step, and provides significantly higher yields in transient cell culture production than IgG. ScFv-Fcs can be effective as neutralizing antibodies in vivo against a panel of pathogens and toxins. However, different scFv fragments are more heterologous in respect of stability than Fab fragments. While some scFv fragments can be made extremely stable, this may change due to few mutations, and is not predictable from the sequence of a newly selected antibody. To mitigate the necessity to assess the stability for every scFv-Fc antibody, we developed a generic lyophilization protocol to improve their shelf life. We compared long-term stability and binding activity of phage display-derived antibodies in the scFv-Fc and IgG format, either stored in liquid or lyophilized state. Conversion of scFv-Fcs into the full IgG format reduced protein degradation and aggregation, but in some cases compromised binding activity. Comparably to IgG conversion, lyophilization of scFv-Fc resulted in the preservation of the antibodies’ initial properties after storage, without any drop in affinity for any of the tested antibody clones.

Highlights

  • Antibodies play a major role in modern medicine and serve as indispensable tools in the field of research, diagnostics and therapy (Borrebaeck, 2000; Rhodes and Trimmer, 2006; Kaplon and Reichert, 2021)

  • We describe a novel single chain Fv (scFv)-Fc lyophilization protocol able to preserve the properties of freshly produced scFv-Fc antibodies over at least six months in terms of molecular mass (MM) distribution and binding activity

  • An initial selection of 55 formulations was screened for their capability to protect a monoclonal anti-c-Myc tag scFvFc antibody (TUN219-2C1-hFc), which was selected for its nonoptimal stability, during lyophilization and subsequent storage

Read more

Summary

Introduction

Antibodies play a major role in modern medicine and serve as indispensable tools in the field of research, diagnostics and therapy (Borrebaeck, 2000; Rhodes and Trimmer, 2006; Kaplon and Reichert, 2021). In vitro selection systems, most prominently antibody phage display, have gained widespread significance (Valldorf et al, 2021). This robust method allows the rapid generation of sequence-defined human antibodies from naïve, immune or synthetic libraries and has become an increasingly meaningful tool in the discovery of antibodies against targets of all kinds (McCafferty et al, 1990; Barbas et al, 1991; Breitling et al, 1991; Kügler et al, 2015; Alfaleh et al, 2020; Wenzel et al, 2020)

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call